GOP lawmaker loses nearly $17 million after pharma stock tanks 92% By: CNBC.com News June 27, 2017 at 16:33 PM EDT The Office of Congressional Ethics is investigating Collins' role as an Innate investor, according to the Buffalo News. Read More >> Related Stocks: Amplia Therapeutics Ltd